LISATA THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (LSTA)

CUSIP: 128058302

Q2 2026 13F Holders as of 30 Jun 2026

Holder snapshot 6 signals
Share change
-201,667
SEC-reported price per share
$3.40
Number of holders
31
Value change
-$1,004,950
Number of buys
12
Number of sells
11
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
9,061,739

Security key

128058302

Report period

Q2 2026

Institutions

31

Top holders

10

Ownership snapshot

Top reported holders of LSTA - LISATA THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Erkki Ruoslahti
Disclosed value leader
Erkki Ruoslahti
Comparable rows
0/15
Latest evidence
31 Mar 2026
3/4/5 13F Highest disclosed value: $3,561,521 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Erkki Ruoslahti has the largest disclosed position value at $3.56M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Erkki Ruoslahti's linked filing trail.
Disclosed position value Top 5
Erkki Ruoslahti $3.56M
Deeter Investments LLP $1.83M
VANGUARD CAPITAL MANAGEMENT LLC $1.36M
Steven S. Myers $668.1K
RENAISSANCE TECHNOLOGIES LLC $659.9K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Erkki Ruoslahti
3/4/5
Director
—
denominator unverified
$3,561,521
1,191,144 shares
— 09 Jan 2023
Deeter Investments LLP
13F
Company
13F
—
denominator unverified
$1,826,040
364,479 shares
— 31 Mar 2026
VANGUARD CAPITAL MANAGEMENT LLC
13F
Company
13F
—
denominator unverified
$1,361,793
271,815 shares
— 31 Mar 2026
Steven S. Myers
3/4/5
Director
—
denominator unverified
$668,142
223,459 shares
— 10 Jan 2022
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
—
denominator unverified
$659,892
131,715 shares
— 31 Mar 2026
Michael H. Davidson
3/4/5
Director
—
denominator unverified
$627,161
209,753 shares
— 10 Jan 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
31
Shares
1,208,300
Rows available
31
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders
34
Q2 2026 holders
31
Holder diff
-3
Investor Q1 2026 Shares Q2 2026 Shares Share Diff Share Chg % Q1 2026 value Q2 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .